Hexobarbital
 | This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. Please improve this article by introducing more precise citations. (October 2009) |
 | This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2009) |
| 200px | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-5-(cyclohex-1-en-1-yl)-1,5-dimethyl-1,3-diazinane-2,4,6-trione | |
| Pharmacokinetic data | |
| Protein binding | 25% |
| Identifiers | |
| CAS Number |
56-29-1 50-09-9 (sodium salt) |
| ATC code | N01AF02 (WHO) N05CA16 |
| PubChem | CID 3608 |
| DrugBank | EXPT03301 |
| ChemSpider | 5545 |
| Chemical data | |
| Formula | C12H16N2O3 |
| Molar mass | 236.267 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
| (verify) | |
Hexobarbital is a barbiturate derivative having hypnotic and sedative effects. It was used in the 1940s-1950s as an agent for inducing anesthesia for surgery and has a relatively fast onset of effects and short duration of action. However it can be difficult to control the depth of anesthesia with hexobarbital which makes it quite dangerous, and it has now been replaced by safer drugs in human medicine, usually thiopental would be the barbiturate of choice for this application these days. Hexobarbital was also marketed as a rapid-acting sleeping medication with short duration (tradenames: Citopan, Evipan and others, usually in 250 mg strength tablets). Hexobarbital is still used in some scientific research.
Further reading
- Takenoshita R, Toki S (2004). "[New aspects of hexobarbital metabolism: stereoselective metabolism, new metabolic pathway via GSH conjugation, and 3-hydroxyhexobarbital dehydrogenases]". Yakugaku Zasshi. 124 (12): 857–71. doi:10.1248/yakushi.124.857. PMID 15577260.
- Wahlström G (1998). "A study of the duration of acute tolerance induced with hexobarbital in male rats". Pharmacol Biochem Behav. 59 (4): 945–8. doi:10.1016/S0091-3057(97)00543-1. PMID 9586853.
- Korkmaz S, Ljungblad E, Wahlström G (1995). "Interaction between flumazenil and the anesthetic effects of hexobarbital in the rat". Brain Res. 676 (2): 371–7. doi:10.1016/0006-8993(95)00132-A. PMID 7614008.
- Dall V, Orntoft U, Schmidt A, Nordholm L (1993). "Interaction of the competitive AMPA receptor antagonist NBQX with hexobarbital". Pharmacol Biochem Behav. 46 (1): 73–6. doi:10.1016/0091-3057(93)90319-O. PMID 8255925.
hu:Hexobarbitál pl:Heksobarbital ru:Гексобарбитал fi:Heksobarbitaali
- Pages with script errors
- Articles lacking in-text citations from October 2009
- Articles with invalid date parameter in template
- All articles lacking in-text citations
- Articles needing additional references from October 2009
- All articles needing additional references
- Pages with broken file links
- Infobox drug articles with non-default infobox title
- Infobox drug tracked parameters
- Articles without EBI source
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- CS1 maint: Multiple names: authors list
- 2Fix
- Barbiturates
- General anesthetics
